{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:45:16Z","timestamp":1793281516970,"version":"4.5.0"},"reference-count":92,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamapsychiatry.2021.0380","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T12:16:03Z","timestamp":1619093763000},"page":"667","source":"Crossref","is-referenced-by-count":150,"title":["Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level"],"prefix":"10.1001","volume":"78","author":[{"given":"Kate","family":"Merritt","sequence":"first","affiliation":[{"name":"Division of Psychiatry, Institute of Mental Health, UCL, London, United Kingdom"},{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip K.","family":"McGuire","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Egerton","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"1H-MRS in Schizophrenia Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Aleman","sequence":"additional","affiliation":[{"name":"Center for Brain Disorder and Cognitive Science, Shenzhen University, Shenzhen, China"},{"name":"University Medical Center Groningen, University of Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Block","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswald J. N.","family":"Bloemen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Borgan","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Bustillo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Center for Psychiatric Research, University of New Mexico School of Medicine, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristides A.","family":"Capizzano","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Neuroradiology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Marie","family":"Coughlin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"De la Fuente-Sandoval","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Psychiatry, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda, Mexico City, Mexico"},{"name":"Neuropsychiatry Department, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsime","family":"Demjaha","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Dempster","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Q.","family":"Do","sequence":"additional","affiliation":[{"name":"Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital-CHUV, Prilly-Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Du","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division, McLean Hospital, Harvard Medical School, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University Hospital, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Galinska-Skok","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Gallinat","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Gasparovic","sequence":"additional","affiliation":[{"name":"Mind Research Network, Albuquerque, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric E.","family":"Ginestet","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience King's College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kokura Gamo Hospital, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[{"name":"Multimodal Neuroimaging Schizophrenia Group, Research Imaging Centre, Geriatric Mental Health Program at Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beng Choon","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Jauhar","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Kegeles","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matcheri","family":"Keshavan","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Philips Healthcare, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[{"name":"National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lauriello","sequence":"additional","affiliation":[{"name":"Jefferson Health-Sidney Kimmel Medical College, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith Jantine","family":"Liemburg","sequence":"additional","affiliation":[{"name":"Rob Giel Research Center, Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Mcilwain","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Auckland, Grafton, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Modinos","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias D.","family":"Mouchlianitis","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Nenadic","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"\u00d6ng\u00fcr","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division, McLean Hospital, Harvard Medical School, Belmont, Massachusetts"},{"name":"Editor, JAMA Psychiatry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ota","sequence":"additional","affiliation":[{"name":"National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Palaniyappan","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Psychiatry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pantelis","sequence":"additional","affiliation":[{"name":"Melbourne Neuropsychiatry Centre, The University of Melbourne and Melbourne Health, Carlton, Victoria, Australia"},{"name":"The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[{"name":"Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada"},{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Posporelis","sequence":"additional","affiliation":[{"name":"Psychosis Studies Department, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"South London and Maudsley, Bethlem Royal Hospital, Beckenham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot E.","family":"Purdon","sequence":"additional","affiliation":[{"name":"Neuropsychology Department, Alberta Hospital Edmonton, Edmonton, Alberta, Canada"},{"name":"Edmonton Early Intervention in Psychosis Clinic, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen R.","family":"Reichenbach","sequence":"additional","affiliation":[{"name":"Medical Physics Group, Institute for Diagnostic and Interventional Radiology, Jena University Hospital, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry F.","family":"Renshaw","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Russell","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sawa","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Mental Health, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy, Psychosomatics and Addiction Medicine, Kliniken Essen-Mitte, Essen, Germany"},{"name":"Department of Psychiatry and Psychotherapy, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Campus Charit\u00e9 Mitte, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikoma C.","family":"Shungu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Smesny","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Stanley","sequence":"additional","affiliation":[{"name":"Brain Imaging Research Division, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London, United Kingdom"},{"name":"Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Szulc","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical University of Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggie","family":"Taylor","sequence":"additional","affiliation":[{"name":"Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom"},{"name":"Lawson Health Research Institute, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Department of Psychology, Michigan State University, East Lansing"},{"name":"Division of Psychiatry and Behavioral Medicine, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Th\u00e9berge","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Psychiatry, Western University, London, Ontario, Canada"},{"name":"Lawson Health Research Institute, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Tibbo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"van Amelsvoort","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Walecki","sequence":"additional","affiliation":[{"name":"Postgraduate Medical School, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Western University, London, Ontario, Canada"},{"name":"Lawson Health Research Institute, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen James","family":"Wood","sequence":"additional","affiliation":[{"name":"Orygen, Melbourne, Australia"},{"name":"Institute for Mental Health, University of Birmingham, Edgbaston, United Kingdom"},{"name":"Centre for Youth Mental Health, University of Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Xin","sequence":"additional","affiliation":[{"name":"Animal Imaging and Technology Core, Center for Biomedical Imaging, Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Yamasue","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7510","key":"yoi210013r1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci.","volume":"511","author":"Ripke","year":"2014","journal-title":"Nature"},{"issue":"7","key":"yoi210013r2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","article-title":"Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies.","volume":"73","author":"Merritt","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"yoi210013r3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.biopsych.2014.07.022","article-title":"N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia.","volume":"77","author":"Anticevic","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"July","key":"yoi210013r4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.schres.2020.06.028","article-title":"A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.","volume":"226","author":"Sydnor","year":"2020","journal-title":"Schizophr Res"},{"issue":"11","key":"yoi210013r5","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","article-title":"Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE).","volume":"23","author":"Egerton","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"6","key":"yoi210013r6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.biopsych.2009.05.006","article-title":"Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.","volume":"66","author":"Stone","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"6","key":"yoi210013r7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/mp.2009.121","article-title":"1H-MRS at 4 tesla in minimally treated early schizophrenia.","volume":"15","author":"Bustillo","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"10","key":"yoi210013r8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/archpsyc.1997.01830220085012","article-title":"Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.","volume":"54","author":"Bartha","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"2-3","key":"yoi210013r9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.schres.2004.08.021","article-title":"Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.","volume":"73","author":"Ohrmann","year":"2005","journal-title":"Schizophr Res"},{"issue":"8","key":"yoi210013r10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jpsychires.2006.07.002","article-title":"Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.","volume":"41","author":"Ohrmann","year":"2007","journal-title":"J Psychiatr Res"},{"issue":"5","key":"yoi210013r11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/schbul\/sbt124","article-title":"Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.","volume":"40","author":"Natsubori","year":"2014","journal-title":"Schizophr Bull"},{"issue":"3","key":"yoi210013r12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/mp.2008.87","article-title":"Proton MRS in twin pairs discordant for schizophrenia.","volume":"15","author":"Lutkenhoff","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"1-3","key":"yoi210013r13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.schres.2008.11.014","article-title":"Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).","volume":"108","author":"Tayoshi","year":"2009","journal-title":"Schizophr Res"},{"issue":"12","key":"yoi210013r14","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","article-title":"Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.","volume":"160","author":"Th\u00e9berge","year":"2003","journal-title":"Am J Psychiatry"},{"key":"yoi210013r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.04.028","article-title":"Progressive cortical reorganisation: a framework for investigating structural changes in schizophrenia.","volume":"79","author":"Palaniyappan","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"yoi210013r16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/npp.2016.172","article-title":"Altered glutamate and regional cerebral blood flow levels in schizophrenia: a 1H-MRS and pCASL study.","volume":"42","author":"Wijtenburg","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"yoi210013r17","first-page":"611","article-title":"Glutamatergic and neuronal dysfunction in gray and white matter: a spectroscopic imaging study in a large schizophrenia sample.","volume":"43","author":"Bustillo","year":"2017","journal-title":"Schizophr Bull"},{"key":"yoi210013r18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1192\/bjp.bp.106.033670","article-title":"Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia.","volume":"191","author":"Th\u00e9berge","year":"2007","journal-title":"Br J Psychiatry"},{"issue":"6","key":"yoi210013r19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1192\/bjp.bp.110.079608","article-title":"Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia.","volume":"198","author":"Aoyama","year":"2011","journal-title":"Br J Psychiatry"},{"issue":"1","key":"yoi210013r20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069","article-title":"Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies.","volume":"39","author":"Marsman","year":"2013","journal-title":"Schizophr Bull"},{"key":"yoi210013r21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fpsyt.2017.00066","article-title":"Effects of antipsychotic administration on brain glutamate in schizophrenia: a systematic review of longitudinal 1H-MRS studies.","volume":"8","author":"Egerton","year":"2017","journal-title":"Front Psychiatry"},{"key":"yoi210013r22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fpsyt.2013.00151","article-title":"Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis.","volume":"4","author":"Merritt","year":"2013","journal-title":"Front Psychiatry"},{"issue":"1","key":"yoi210013r23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/acps.2012.126.issue-1","article-title":"Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.","volume":"126","author":"Ota","year":"2012","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"yoi210013r24","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/npp.2012.113","article-title":"Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia.","volume":"37","author":"Egerton","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"yoi210013r25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/schbul\/sbv151","article-title":"Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive.","volume":"42","author":"Mouchlianitis","year":"2016","journal-title":"Schizophr Bull"},{"key":"yoi210013r26","journal-title":"NPJ Schizophr"},{"issue":"5","key":"yoi210013r28","article-title":"A brief introduction to mixed effects modelling and multi-model inference in ecology.","volume":"6","author":"Harrison","year":"2018","journal-title":"PeerJ"},{"issue":"1","key":"yoi210013r31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/anzs.2019.61.issue-1","article-title":"A note on model selection using information criteria for general linear models estimated using REML.","volume":"61","author":"Verbyla","year":"2019","journal-title":"Aust N Z J Stat"},{"issue":"9","key":"yoi210013r32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/npp.2011.65","article-title":"Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.","volume":"36","author":"de la Fuente-Sandoval","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"yoi210013r33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/ijnp\/pyx076","article-title":"Cortical GABA in subjects at ultra-high risk of psychosis: relationship to negative prodromal symptoms.","volume":"21","author":"Modinos","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"yoi210013r34","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv105","article-title":"Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy.","volume":"19","author":"de la Fuente-Sandoval","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"yoi210013r35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamapsychiatry.2013.3939","article-title":"Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.","volume":"71","author":"Bustillo","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"yoi210013r36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1566524015666150303104811","article-title":"Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.","volume":"15","author":"Coughlin","year":"2015","journal-title":"Curr Mol Med"},{"issue":"3","key":"yoi210013r37","first-page":"248","article-title":"Decoupling of brain temperature and glutamate in recent onset of schizophrenia: a 7T proton magnetic resonance spectroscopy study.","volume":"3","author":"Posporelis","year":"2018","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"1","key":"yoi210013r38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1192\/bjpo.bp.116.003756","article-title":"Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T.","volume":"3","author":"Taylor","year":"2017","journal-title":"BJPsych Open"},{"issue":"4","key":"yoi210013r39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/schbul\/22.4.597","article-title":"An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.","volume":"22","author":"Stanley","year":"1996","journal-title":"Schizophr Bull"},{"issue":"2","key":"yoi210013r40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/schbul\/sbv124","article-title":"Cross-sectional study of glutamate in the anterior cingulate and hippocampus in schizophrenia.","volume":"42","author":"Gallinat","year":"2016","journal-title":"Schizophr Bull"},{"issue":"1-3","key":"yoi210013r41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2007.03.028","article-title":"Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.","volume":"93","author":"Stanley","year":"2007","journal-title":"Schizophr Res"},{"issue":"5","key":"yoi210013r42","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/schbul\/sbw038","article-title":"Genetic polymorphism associated prefrontal glutathione and its coupling with brain glutamate and peripheral redox status in early psychosis.","volume":"42","author":"Xin","year":"2016","journal-title":"Schizophr Bull"},{"issue":"1-2","key":"yoi210013r43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.schres.2015.07.013","article-title":"Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.","volume":"168","author":"Smesny","year":"2015","journal-title":"Schizophr Res"},{"issue":"1","key":"yoi210013r44","doi-asserted-by":"publisher","first-page":"21873","DOI":"10.1038\/srep21873","article-title":"Prefrontal NAA and Glx levels in different stages of psychotic disorders: a 3T 1H-MRS study.","volume":"6","author":"Liemburg","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"yoi210013r45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.biopsych.2017.08.022","article-title":"In vivo brain glycine and glutamate concentrations in patients with first-episode psychosis measured by echo time-averaged proton magnetic resonance spectroscopy at 4T.","volume":"83","author":"Kim","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"10","key":"yoi210013r46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2215-0366(18)30268-2","article-title":"The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.","volume":"5","author":"Jauhar","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"yoi210013r47","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1038\/s41598-019-45018-0","article-title":"Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study.","volume":"9","author":"Borgan","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"yoi210013r48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: a proton magnetic resonance spectroscopy study with implications for glial dysfunction.","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr Bull"},{"key":"yoi210013r49","first-page":"119","article-title":"Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia.","volume":"8","author":"Goto","year":"2012","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"yoi210013r50","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.","volume":"159","author":"Th\u00e9berge","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"3","key":"yoi210013r51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/mrm.24291","article-title":"3-T proton magnetic spectroscopy in unmedicated first episode psychosis: a focus on creatine.","volume":"69","author":"Tibbo","year":"2013","journal-title":"Magn Reson Med"},{"issue":"2","key":"yoi210013r52","first-page":"CR82","article-title":"Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.","volume":"15","author":"Galinska","year":"2009","journal-title":"Med Sci Monit"},{"issue":"1-3","key":"yoi210013r53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.schres.2008.03.012","article-title":"A 1H-MRS investigation of the medial temporal lobe in antipsychotic-na\u00efve and early-treated first episode psychosis.","volume":"102","author":"Wood","year":"2008","journal-title":"Schizophr Res"},{"issue":"1-3","key":"yoi210013r54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.schres.2007.05.008","article-title":"Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.","volume":"94","author":"Wood","year":"2007","journal-title":"Schizophr Res"},{"issue":"3","key":"yoi210013r55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0925-4927(00)00044-5","article-title":"Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.","volume":"98","author":"Kegeles","year":"2000","journal-title":"Psychiatry Res"},{"issue":"4","key":"yoi210013r56","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/s-0031-1279739","article-title":"Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.","volume":"44","author":"Szulc","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"yoi210013r57","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu117","article-title":"Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.","volume":"18","author":"Goldstein","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"yoi210013r58","author":"Block","journal-title":"Neurosci Lett"},{"issue":"7","key":"yoi210013r59","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2010.05.016","article-title":"Elevated gamma-aminobutyric acid levels in chronic schizophrenia.","volume":"68","author":"\u00d6ng\u00fcr","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"8","key":"yoi210013r60","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.biopsych.2008.05.014","article-title":"Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.","volume":"64","author":"\u00d6ng\u00fcr","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"5","key":"yoi210013r61","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/neu.2015.22","article-title":"Effect of l-theanine on glutamatergic function in patients with schizophrenia.","volume":"27","author":"Ota","year":"2015","journal-title":"Acta Neuropsychiatr"},{"issue":"5","key":"yoi210013r62","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/archgenpsychiatry.2011.1519","article-title":"Elevated prefrontal cortex ?-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.","volume":"69","author":"Kegeles","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"yoi210013r63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1017\/S1461145703003687","article-title":"Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.","volume":"6","author":"Yamasue","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"issue":"13","key":"yoi210013r64","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1038\/s41386-017-0004-6","article-title":"Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.","volume":"43","author":"Modinos","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"yoi210013r65","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"12","key":"yoi210013r66","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1038\/npp.2014.143","article-title":"Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.","volume":"39","author":"Egerton","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1-3","key":"yoi210013r67","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.schres.2011.05.024","article-title":"Magnetic resonance spectroscopy of limbic structures displays metabolite differences in young unaffected relatives of schizophrenia probands.","volume":"131","author":"Capizzano","year":"2011","journal-title":"Schizophr Res"},{"issue":"1","key":"yoi210013r68","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.biopsych.2010.11.030","article-title":"Hippocampal glutamate levels and striatal dopamine D2\/3 receptor occupancy in subjects at ultra high risk of psychosis.","volume":"70","author":"Bloemen","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"8","key":"yoi210013r69","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41380-020-0704-x","article-title":"Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate.","volume":"25","author":"Dempster","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"8","key":"yoi210013r70","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1017\/S0033291709991711","article-title":"White-matter markers for psychosis in a prospective ultra-high-risk cohort.","volume":"40","author":"Bloemen","year":"2010","journal-title":"Psychol Med"},{"key":"yoi210013r71","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neurobiolaging.2020.07.015","article-title":"A quantitative meta-analysis of brain glutamate metabolites in aging.","volume":"95","author":"Roalf","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"1","key":"yoi210013r72","first-page":"119","article-title":"Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.","volume":"22","author":"Angelie","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"yoi210013r73","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ejrad.2007.08.038","article-title":"Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.","volume":"68","author":"Gruber","year":"2008","journal-title":"Eur J Radiol"},{"key":"yoi210013r74","author":"Chang","journal-title":"Life Sci"},{"issue":"2","key":"yoi210013r75","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(ISSN)1522-2594","article-title":"In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging.","volume":"41","author":"Pfefferbaum","year":"1999","journal-title":"Magn Reson Med"},{"issue":"7","key":"yoi210013r76","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/cercor\/11.7.598","article-title":"A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations.","volume":"11","author":"Brooks","year":"2001","journal-title":"Cereb Cortex"},{"issue":"12","key":"yoi210013r77","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1097\/00005072-199712000-00001","article-title":"Aging-associated changes in human brain.","volume":"56","author":"Mrak","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"yoi210013r78","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Neocortical cell counts in normal human adult aging.","volume":"21","author":"Terry","year":"1987","journal-title":"Ann Neurol"},{"issue":"3","key":"yoi210013r79","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41386-018-0236-0","article-title":"Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study.","volume":"44","author":"Legind","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"yoi210013r80","article-title":"Progressive changes in glutamate concentration in early stages of schizophrenia: a longitudinal 7-Tesla MRS study.","author":"Jeon","journal-title":"Schizophr Bull"},{"key":"yoi210013r81","journal-title":"Neural Plast"},{"issue":"4","key":"yoi210013r82","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jchemneu.2003.10.003","article-title":"The primate basal ganglia: parallel and integrative networks.","volume":"26","author":"Haber","year":"2003","journal-title":"J Chem Neuroanat"},{"issue":"6","key":"yoi210013r83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.biopsych.2017.09.028","article-title":"Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients.","volume":"83","author":"de la Fuente-Sandoval","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"7","key":"yoi210013r84","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.biopsych.2018.09.009","article-title":"Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study.","volume":"85","author":"Iwata","year":"2019","journal-title":"Biol Psychiatry"},{"issue":"4","key":"yoi210013r85","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41386-019-0589-z","article-title":"Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.","volume":"45","author":"Tarumi","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"yoi210013r86","article-title":"Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: a multicenter positron emission tomography and magnetic resonance spectroscopy study (STRATA).","author":"Egerton","journal-title":"Schizophr Bull"},{"issue":"1","key":"yoi210013r87","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/schbul\/sbx199","article-title":"The circuitry of dopamine system regulation and its disruption in schizophrenia: insights into treatment and prevention.","volume":"45","author":"Grace","year":"2019","journal-title":"Schizophr Bull"},{"issue":"5","key":"yoi210013r88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2005.05.002","article-title":"The hippocampal-VTA loop: controlling the entry of information into long-term memory.","volume":"46","author":"Lisman","year":"2005","journal-title":"Neuron"},{"issue":"9","key":"yoi210013r89","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fninf.2018.00102","article-title":"An empirical comparison of meta- and mega-analysis with data from the ENIGMA Obsessive-Compulsive Disorder Working Group.","volume":"12","author":"Boedhoe","year":"2019","journal-title":"Front Neuroinform"},{"issue":"2","key":"yoi210013r90","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/schbul\/sbz067","article-title":"Towards precision medicine in psychosis: benefits and challenges of multimodal multicenter studies\u2014PSYSCAN: translating neuroimaging findings from research into clinical practice.","volume":"46","author":"Tognin","year":"2020","journal-title":"Schizophr Bull"},{"issue":"6","key":"yoi210013r91","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00004424-199606000-00006","article-title":"Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy.","volume":"31","author":"Choe","year":"1996","journal-title":"Invest Radiol"},{"key":"yoi210013r92","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.schres.2020.03.069","article-title":"Treatment effects on neurometabolite levels in schizophrenia: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.","volume":"222","author":"Kubota","year":"2020","journal-title":"Schizophr Res"},{"key":"yoi210013r30","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2009"},{"key":"yoi210013r27","unstructured":"Provencher? S. LCModel & LCMgui User\u2019s Manual. Published February 4, 2021. Accessed March 6, 2021. http:\/\/s-provencher.com\/pub\/LCModel\/manual\/manual.pdf"},{"key":"yoi210013r29","unstructured":"R Core Team. The R Project for Statistical Computing. Accessed March 6, 2021. https:\/\/www.r-project.org\/."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2778479\/jamapsychiatry_merritt_2021_oi_210013_1622231677.56011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T15:58:22Z","timestamp":1622649502000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2778479"}},"subtitle":["A Mega-analysis of Individual Participant-Level Data"],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0380","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}